Maternal urinary phthalates and sex-specific placental mRNA levels in an urban birth cohort

DSpace/Manakin Repository

Maternal urinary phthalates and sex-specific placental mRNA levels in an urban birth cohort

Citable link to this page


Title: Maternal urinary phthalates and sex-specific placental mRNA levels in an urban birth cohort
Author: Adibi, Jennifer J.; Buckley, Jessie P.; Lee, Myoung Keun; Williams, Paige L.; Just, Allan C.; Zhao, Yaqi; Bhat, Hari K.; Whyatt, Robin M.

Note: Order does not necessarily reflect citation order of authors.

Citation: Adibi, Jennifer J., Jessie P. Buckley, Myoung Keun Lee, Paige L. Williams, Allan C. Just, Yaqi Zhao, Hari K. Bhat, and Robin M. Whyatt. 2017. “Maternal urinary phthalates and sex-specific placental mRNA levels in an urban birth cohort.” Environmental Health 16 (1): 35. doi:10.1186/s12940-017-0241-5.
Full Text & Related Files:
Abstract: Background: Prenatal urinary concentrations of phthalates in women participants in an urban birth cohort were associated with outcomes in their children related to neurodevelopment, autoimmune disease risk, and fat mass at 3,5,7, and 8 years of life. Placental biomarkers and outcomes at birth may offer biologic insight into these associations. This is the first study to address these associations with candidate genes from the phthalate and placenta literature, accounting for sex differences, and using absolute quantitation methods for mRNA levels. Methods: We measured candidate mRNAs in 180 placentas sampled at birth (HSD17B1, AHR, CGA, CYP19A1, SLC27A4, PTGS2, PPARG, CYP11A1) by quantitative PCR and an absolute standard curve. We estimated associations of loge mRNA with quartiles of urinary phthalate monoesters using linear mixed models. Phthalate metabolites (N = 358) and mRNAs (N = 180) were transformed to a z-score and modeled as independent, correlated vectors in relation to large for gestational age (LGA) and gestational diabetes mellitus (GDM). Results: CGA was associated with 4 out of 6 urinary phthalates. CGA was 2.0 loge units lower at the 3rd vs. 1st quartile of mono-n-butyl phthalate (MnBP) (95% confidence interval (CI): −3.5, −0.5) in male placentas, but 0.6 loge units higher (95% CI: −0.8, 1.9) in female placentas (sex interaction p = 0.01). There was an inverse association of MnBP with PPARG in male placentas (−1.1 loge units at highest vs. lowest quartile, 95% CI: −2.0, −0.1). CY19A1, CYP11A1, CGA were associated with one or more of the following in a sex-specific manner: monobenzyl phthalate (MBzP), MnBP, mono-iso-butyl phthalate (MiBP). These 3 mRNAs were lower by 1.4-fold (95% CI: −2.4, -1.0) in male GDM placentas vs. female and non-GDM placentas (p-value for interaction = 0.04). The metabolites MnBP/MiBP were 16% higher (95% CI: 0, 22) in GDM pregnancies. Conclusions: Prenatal concentrations of certain phthalates and outcomes at birth were modestly associated with molecular changes in fetal placental tissue during pregnancy. Associations were stronger in male vs. female placentas, and associations with MnBP and MiBP were stronger than other metabolites. Placental mRNAs are being pursued further as potential mediators of exposure-induced risks to the health of the child. Electronic supplementary material The online version of this article (doi:10.1186/s12940-017-0241-5) contains supplementary material, which is available to authorized users.
Published Version: doi:10.1186/s12940-017-0241-5
Other Sources:
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at
Citable link to this page:
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search